HonorHealth Research Institute has initiated a groundbreaking 12-week clinical trial examining steam therapy as a novel treatment for type 2 diabetes, marking the first investigation of its kind in the United States. The study evaluates controlled heat exposure sessions designed to enhance insulin sensitivity and glucose metabolism through heat-induced physiological changes.
This innovative approach represents a significant departure from conventional diabetes management strategies. Researchers hypothesize that repeated thermal stress activates heat shock proteins and cellular pathways that improve glucose uptake and metabolic function. The protocol involves medically supervised steam sessions with continuous monitoring of vital signs and glucose levels.
Given that more than 37 million Americans have diabetes—with 90-95% having type 2—this research addresses a critical public health need. Many patients currently struggle to achieve optimal glucose control through lifestyle modifications, oral medications, and insulin therapy alone.
Was this article helpful?
